Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-24T10:43:40.723Z Has data issue: false hasContentIssue false
  • English
  • Français

Síndrome de Charles Bonnet y enfermedad de Parkinson

Published online by Cambridge University Press:  12 May 2020

A. G. Alcántara ,
L. Valenciano ,
A. Díaz-Ortuño ,
M. L. Martínez-Navarro  and
D. Barcía
A. G. Alcántara
Affiliation:
Departamento de Psiquiatría
L. Valenciano
Affiliation:
Departamento de Psiquiatría
A. Díaz-Ortuño
Affiliation:
Sección de Neurología, Departamento de Medicina Interna, Hospital General Universitario, Av. Intendente J. Palacios 1,30003Murcia, España
M. L. Martínez-Navarro
Affiliation:
Sección de Neurología, Departamento de Medicina Interna, Hospital General Universitario, Av. Intendente J. Palacios 1,30003Murcia, España
D. Barcía
Affiliation:
Departamento de Psiquiatría
Get access

Resumen

Presentamos dos casos de síndrome de Charles Bonnet en comorbilidad con enfermedad de Parkinson. Los pacientes desarrollaron alucinosis visual antes de comenzar el tratamiento antiparkinsoniano. Analizamos brevemente los posibles mecanismos fisiopatológicos que implican a la agudeza visual baja y la enfermedad de Parkinson con la alucinosis visual.

Keywords

síndrome de Charles Bonnetenfermedad de Parkinsonalucinosis visualagudeza visual baja
Type
Informe Clínico
Information
European Psychiatry (Ed. Española) , Volume 6 , Issue 3 , April 1999 , pp. 182 - 194
Copyright
Copyright © European Psychiatric Association 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Factor, SA, Molho, Podskalny, GD, Brown, D, Parkinson’s disease: drug-induced psychiatric States. In: Weiner, WJ, Lang, E, eds. Behavioural neurology of movement disorders. New York: Raven Press; 1995; 115–38.Google Scholar
Fernandez, A, Lichtshein, G, Viegweg, WV. The Charles Bonnet syndrome: a review. J Nery Ment Dis 1997; 185: 195–200.CrossRefGoogle ScholarPubMed
Middleton, FA, Strick, PL. The temporal lobe is a target of output from the basal ganglia. Proc Nati Acad Sci USA 1996; 93: 8683–7.CrossRefGoogle ScholarPubMed
Podoll, K, Osterheider, M, Noth, J.Das Charles Bonnet-Syndrom. Fortschr Neurol Psychiat 1989; 57: 43–60.CrossRefGoogle Scholar
Podoll, K, Schwarz, M, Noth, J.Charles Bonnet-Syndrom bei einem Parkinson-Patienten mit beidseitigem Visusverlust. Nervenarzt 1990; 61: 52–6.Google Scholar
Teunisse, RJ, Zitman, FG, Raes, DCM. Clinical evaluation of 14 patients with the Charles Bonnet syndrome (isolated visual hallucinations). Compr Psychiatry 1994; 35: 70–5.CrossRefGoogle Scholar
Weinberger, LM, Grant, FC. Visual hallucinations and their neuro-optical correlates. Arch Ophthalmol (Chicago) 1940; 23: 166–99.CrossRefGoogle Scholar
West, LJ. A general theory of hallucinations. In: West, LJ, ed. Hallucinations. New York: Grane & Stratton; 1962; 275–91.Google Scholar